Jiangsu Nhwa Pharmaceutical Co., Ltd.

This study tested whether a new drug called NH102 can help reduce symptoms of major depression. Researchers compared three different doses of NH102 against a placebo (inactive pill) and an existing antidepressant (duloxetine) in 243 adults with depression. The main goal was to se…

This early-stage study tested a new oral drug called NH280105, which is being developed for Alzheimer's disease. The trial involved 32 healthy adult volunteers to check if the drug is safe and how the body processes it. Researchers gave participants single and multiple doses to m…

This is a very early study to check the safety of a new drug called NH102, which is being developed to treat depression. It tested multiple dose levels in 40 healthy volunteers to see how their bodies reacted to and processed the drug. The main goal was to find out what side effe…